Oncologic Outcomes Following Three Different Approaches to the Distal Ureter and Bladder Cuff in Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma

医学 袖口 上尿路 泌尿科 输尿管 膀胱癌 泌尿系统 外科 尿路上皮 回顾性队列研究 膀胱 癌症 内科学
作者
Wei‐Ming Li,Jung‐Tsung Shen,Ching‐Chia Li,Hung‐Lung Ke,Yu‐Ching Wei,Wen‐Jeng Wu,Yii‐Her Chou,Chun‐Hsiung Huang
出处
期刊:European Urology [Elsevier BV]
卷期号:57 (6): 963-969 被引量:182
标识
DOI:10.1016/j.eururo.2009.12.032
摘要

There is a lack of consensus regarding the prognostic significance of different approaches to the bladder cuff at surgery for primary upper urinary tract urothelial carcinoma (UUT-UC). To compare the oncologic outcomes following radical nephroureterectomy using three different methods of managing the bladder cuff. From January 1990 to December 2007, 414 patients with primary UUT-UC underwent radical nephroureterectomy at our institution. Of these, 301 were included in our study. Three methods of bladder cuff excision—intravesical incision, extravesical incision, and transurethral incision (TUI)—were performed. Patients’ medical records were reviewed retrospectively. The clinicopathologic data and oncologic outcomes were compared among groups. Of the 301 patients, 81 (26.9%) underwent the intravesical method, 129 (42.9%) underwent the extravesical technique, and 91 (30.2%) underwent TUI. There were no differences in clinical and histopathologic data among the three groups. When comparing the intravesical, extravesical, and TUI techniques, bladder recurrence developed in, respectively, 23.5%, 24.0%, and 17.6% cases (p = 0.485); local retroperitoneal recurrence in 7.4%, 7.8%, and 5.5% (p = 0.798); contralateral recurrence in 4.9%, 3.9%, and 2.2% (p = 0.632); and distant metastasis in 7.4%, 10.4%, and 5.5% (p = 0.564). There were no differences in recurrence-free and cancer-specific survival among the three groups (p = 0.680 and 0.502, respectively). The three techniques had comparable oncologic outcomes. Our data validate the TUI method of bladder cuff control in patients with primary UUT-UC without coexistent bladder tumors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
shmily13333完成签到 ,获得积分10
刚刚
Enquinn完成签到,获得积分10
1秒前
卜小卜发布了新的文献求助10
2秒前
ying完成签到,获得积分10
3秒前
SciGPT应助shaangu623采纳,获得30
4秒前
刘总完成签到 ,获得积分10
5秒前
九九乘法表完成签到,获得积分10
5秒前
MZP完成签到,获得积分10
5秒前
等待鸽子完成签到,获得积分10
5秒前
鲸鱼打滚完成签到 ,获得积分10
5秒前
hhh完成签到,获得积分10
6秒前
过时的天蓝完成签到,获得积分20
6秒前
7秒前
狂炫砂糖柑完成签到,获得积分10
8秒前
wangyanyan发布了新的文献求助10
8秒前
XDMae发布了新的文献求助10
10秒前
11秒前
shaangu623完成签到,获得积分20
11秒前
笔记本完成签到,获得积分0
11秒前
锵锵锵完成签到,获得积分10
12秒前
笨笨青筠完成签到 ,获得积分0
12秒前
天天快乐应助melody采纳,获得10
13秒前
奋斗的大白菜完成签到,获得积分10
13秒前
咕噜噜完成签到 ,获得积分10
14秒前
14秒前
14秒前
文艺的哑铃关注了科研通微信公众号
14秒前
和平港湾完成签到,获得积分10
15秒前
suibian完成签到,获得积分10
15秒前
小蜗牛发布了新的文献求助10
16秒前
酷酷菲音完成签到,获得积分10
16秒前
melens完成签到,获得积分10
16秒前
胖仔没烦恼完成签到,获得积分10
16秒前
Zhanghao完成签到,获得积分10
17秒前
共享精神应助fan采纳,获得10
17秒前
云来如梦完成签到,获得积分10
18秒前
852应助Du采纳,获得10
20秒前
甄遥完成签到,获得积分10
21秒前
21秒前
刘总完成签到 ,获得积分10
22秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7298408
求助须知:如何正确求助?哪些是违规求助? 8916795
关于积分的说明 18879891
捐赠科研通 6963494
什么是DOI,文献DOI怎么找? 3210653
关于科研通互助平台的介绍 2379981
邀请新用户注册赠送积分活动 2187144